SLU-PP-332 and Tirzepatide Interaction

Monitor
Researched 90% confidence

SLU-PP-332 and Tirzepatide have an interaction requiring monitoring for interaction with 90% confidence. Different mechanisms affecting weight loss and metabolism - combination could have additive effects. Both compounds affect the pancreas, so monitoring these systems is recommended.

Compound Profiles

SLU-PP-332

Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator

Binds and activates ERRα/β/γ which regulate energy metabolism gene expression. Upregulates PGC-1α (mitochondrial biogenesis master regulator), activates AMPK pathway, increases mitochondrial density to 1.

Half-life: Under investigation (no human PK data) Typical dose: NO HUMAN DOSE ESTABLISHED (animal studies: 50 mg/kg IP) metabolic, longevity
ampk hepatotoxicinsulin disrupting
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

Pancreas
low
GI Tract
low

Frequently Asked Questions

Can I take SLU-PP-332 with Tirzepatide?

Yes, but with caution. Different mechanisms affecting weight loss and metabolism - combination could have additive effects. Regular monitoring is advised.

Is SLU-PP-332 and Tirzepatide safe together?

Based on documented research, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between SLU-PP-332 and Tirzepatide?

Different mechanisms affecting weight loss and metabolism - combination could have additive effects. This assessment has 90% confidence and is based on documented research data.

How should I time SLU-PP-332 and Tirzepatide?

SLU-PP-332 has a half-life of Under investigation (no human PK data) and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: SLU-PP-332 vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.